Bill Text: NY S02805 | 2013-2014 | General Assembly | Introduced
Bill Title: Relates to requirements for electronic prescribing software under the medical assistance program; prohibits the use of advertising or messaging in such software; requires such software to include a means for prior authorization approval; prohibits use of certain information relating to a patient's benefits plan.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2014-01-08 - REFERRED TO HEALTH [S02805 Detail]
Download: New_York-2013-S02805-Introduced.html
S T A T E O F N E W Y O R K ________________________________________________________________________ 2805 2013-2014 Regular Sessions I N S E N A T E January 23, 2013 ___________ Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law and the education law, in relation to electronic prescribing software THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: 1 Section 1. Section 281 of the public health law is amended by adding a 2 new subdivision 7 to read as follows: 3 7. THE REGULATIONS PROMULGATED PURSUANT TO SUBDIVISION THREE OF THIS 4 SECTION SHALL PROVIDE THAT ALL ELECTRONIC PRESCRIBING SOFTWARE USED IN 5 THIS STATE INCLUDING, WITHOUT LIMITATION, ELECTRONIC PRESCRIBING SOFT- 6 WARE FOR WHICH PRESCRIBERS AND PHARMACIES RECEIVE PAYMENTS PURSUANT TO 7 SECTION THREE HUNDRED SIXTY-SEVEN-A OF THE SOCIAL SERVICES LAW SHALL: 8 (A) TRANSMIT TO A PRESCRIBER ONLY ELECTRONIC COMMUNICATIONS CONSISTENT 9 WITH THE PRODUCT LABEL EXCEPT WHERE SUCH COMMUNICATION RELATES TO A 10 REVIEW ARTICLE OR EDITORIAL COMMENT IN A MAJOR PEER REVIEWED PROFES- 11 SIONAL JOURNAL, SUPPORTED BY SCIENTIFIC EVIDENCE AND THAT MEETS THE 12 FEDERAL FOOD AND DRUG ADMINISTRATION REQUIREMENTS FOR ADVERTISING PHAR- 13 MACEUTICAL PRODUCTS; 14 (B) NOT USE ANY MEANS OR PERMIT ANY OTHER PERSON TO USE ANY MEANS, 15 INCLUDING, BUT NOT LIMITED TO, ADVERTISING, INSTANT MESSAGING, AND POP- 16 UP ADS, TO INFLUENCE OR ATTEMPT TO INFLUENCE, THROUGH ECONOMIC INCEN- 17 TIVES OR OTHERWISE, THE PRESCRIBING DECISION OF A PRESCRIBING PRACTI- 18 TIONER AT THE POINT OF CARE OR ANY SUCH MEANS TRIGGERED OR IN SPECIFIC 19 RESPONSE TO THE INPUT, SELECTION, OR ANY ACT OF A PRESCRIBING PRACTI- 20 TIONER OR HIS OR HER AGENT IN PRESCRIBING A CERTAIN PHARMACEUTICAL OR 21 DIRECTING A PATIENT TO A CERTAIN PHARMACY; 22 (C) NOT SHOW INFORMATION REGARDING A PAYOR'S FORMULARY, CO-PAYMENT OR 23 BENEFIT PLAN IN ANY WAY THAT PRECLUDES OR MAKES MORE DIFFICULT THE ACT 24 OF A PRESCRIBING PRACTITIONER OR PATIENT SELECTING ANY PARTICULAR PHAR- 25 MACY OR PHARMACEUTICAL; AND EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD04350-03-3 S. 2805 2 1 (D) MAKE AVAILABLE MEANS TO REQUEST A PRIOR AUTHORIZATION APPROVAL AND 2 RECEIVE PRIOR AUTHORIZATION AND STEP THERAPY CRITERIA AND APPROVAL ELEC- 3 TRONICALLY ON THE DAY THE PRESCRIPTION IS ISSUED AS ESTABLISHED VIA A 4 STANDARDIZED FORMAT TO BE CREATED BY THE BOARD OF PHARMACY. 5 S 2. Section 6810 of the education law is amended by adding a new 6 subdivision 14 to read as follows: 7 14. THE REGULATIONS PROMULGATED PURSUANT TO SUBDIVISION TEN OF THIS 8 SECTION SHALL PROVIDE THAT ALL ELECTRONIC PRESCRIBING SOFTWARE USED IN 9 THIS STATE INCLUDING, WITHOUT LIMITATION, ELECTRONIC PRESCRIBING SOFT- 10 WARE FOR WHICH PRESCRIBERS AND PHARMACIES RECEIVE PAYMENTS PURSUANT TO 11 SECTION THREE HUNDRED SIXTY-SEVEN-A OF THE SOCIAL SERVICES LAW SHALL: 12 (A) TRANSMIT TO A PRESCRIBER ONLY ELECTRONIC COMMUNICATIONS CONSISTENT 13 WITH THE PRODUCT LABEL EXCEPT WHERE SUCH COMMUNICATION RELATES TO A 14 REVIEW ARTICLE OR EDITORIAL COMMENT IN A MAJOR PEER REVIEWED PROFES- 15 SIONAL JOURNAL, SUPPORTED BY SCIENTIFIC EVIDENCE AND THAT MEETS THE 16 FEDERAL FOOD AND DRUG ADMINISTRATION REQUIREMENTS FOR ADVERTISING PHAR- 17 MACEUTICAL PRODUCTS; 18 (B) NOT USE ANY MEANS OR PERMIT ANY OTHER PERSON TO USE ANY MEANS, 19 INCLUDING, BUT NOT LIMITED TO, ADVERTISING, INSTANT MESSAGING, AND POP- 20 UP ADS, TO INFLUENCE OR ATTEMPT TO INFLUENCE, THROUGH ECONOMIC INCEN- 21 TIVES OR OTHERWISE, THE PRESCRIBING DECISION OF A PRESCRIBING PRACTI- 22 TIONER AT THE POINT OF CARE OR ANY SUCH MEANS TRIGGERED OR IN SPECIFIC 23 RESPONSE TO THE INPUT, SELECTION, OR ANY ACT OF A PRESCRIBING PRACTI- 24 TIONER OR HIS OR HER AGENT IN PRESCRIBING A CERTAIN PHARMACEUTICAL OR 25 DIRECTING A PATIENT TO A CERTAIN PHARMACY; 26 (C) NOT SHOW INFORMATION REGARDING A PAYOR'S FORMULARY, CO-PAYMENT OR 27 BENEFIT PLAN IN ANY WAY THAT PRECLUDES OR MAKES MORE DIFFICULT THE ACT 28 OF A PRESCRIBING PRACTITIONER OR PATIENT SELECTING ANY PARTICULAR PHAR- 29 MACY OR PHARMACEUTICAL; AND 30 (D) MAKE AVAILABLE MEANS TO REQUEST A PRIOR AUTHORIZATION APPROVAL AND 31 RECEIVE PRIOR AUTHORIZATION AND STEP THERAPY CRITERIA AND APPROVAL ELEC- 32 TRONICALLY ON THE DAY THE PRESCRIPTION IS ISSUED AS ESTABLISHED VIA A 33 STANDARDIZED FORMAT TO BE CREATED BY THE BOARD OF PHARMACY. 34 S 3. This act shall take effect immediately.